Yano, S.; Kawaoka, T.; Yamasaki, S.; Johira, Y.; Kosaka, M.; Shirane, Y.; Miura, R.; Amioka, K.; Naruto, K.; Yamaoka, K.;
et al. Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Cancers 2023, 15, 5406.
https://doi.org/10.3390/cancers15225406
AMA Style
Yano S, Kawaoka T, Yamasaki S, Johira Y, Kosaka M, Shirane Y, Miura R, Amioka K, Naruto K, Yamaoka K,
et al. Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Cancers. 2023; 15(22):5406.
https://doi.org/10.3390/cancers15225406
Chicago/Turabian Style
Yano, Shigeki, Tomokazu Kawaoka, Shintaro Yamasaki, Yusuke Johira, Masanari Kosaka, Yuki Shirane, Ryoichi Miura, Kei Amioka, Kensuke Naruto, Kenji Yamaoka,
and et al. 2023. "Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma" Cancers 15, no. 22: 5406.
https://doi.org/10.3390/cancers15225406
APA Style
Yano, S., Kawaoka, T., Yamasaki, S., Johira, Y., Kosaka, M., Shirane, Y., Miura, R., Amioka, K., Naruto, K., Yamaoka, K., Fujii, Y., Uchikawa, S., Fujino, H., Ono, A., Nakahara, T., Murakami, E., Miki, D., Tsuge, M., Teraoka, Y.,
... Oka, S.
(2023). Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Cancers, 15(22), 5406.
https://doi.org/10.3390/cancers15225406
